# DESCRIPTION

## GOVERNMENT LICENSE RIGHTS

- acknowledge government support

## FIELD

- define subject technology

## BACKGROUND

- describe AD neuropathology
- summarize current understanding of AD

## SUMMARY

- introduce method of treating AD
- describe calcium-release stabilizing molecules
- outline administration methods
- introduce method of diagnosing AD
- describe detection of gene expression
- outline embodiments of diagnosis method
- preview additional features

## DETAILED DESCRIPTION

- introduce background on Ca2+ dysregulation in aging hippocampal neurons
- motivate FKBP1b as key molecule in Ca2+ homeostasis
- describe unexpected discovery of Fkbp1b overexpression improving maze learning and/or memory
- outline therapeutic methods for treating Alzheimer's Disease using Ca2+-release stabilizing molecules
- describe diagnostic methods for detecting Alzheimer's Disease based on gene expression levels

### DEFINITIONS

- define early-stage AD
- describe intermediate stage AD
- describe late or severe stage of AD
- define mild cognitive impairment (MCI)
- define elevated risk of AD
- define subject
- define inhibit
- define therapeutically effective amount
- define pharmaceutically acceptable
- define treat
- define promote
- define reference or control
- define about and approximately
- define differential expression
- define polypeptide
- define hybridization
- define target
- define panel of targets
- define small molecule
- define large molecule
- describe previous studies on immunophilins, junctophilins, and calmodulin 3
- describe recent studies on FKBP1b and Ca2+ dysregulation
- describe ryanodine receptors and inositol trisphosphate receptor

### I. Isolated Nucleic Acid Molecules Encoding Ca2+ Release-Stabilizing Molecules

- define isolated nucleic acid molecules
- describe encoding of Ca2+ release-stabilizing molecules
- introduce nucleic acid sequences of Fkbp1a, Fkbp1b variant_a, Fkbp1b variant_b, Junct
- describe obtaining variant molecules with similar activity
- introduce isolated nucleic acid fragments as hybridization probes
- describe use of nucleic acid molecules as PCR primers
- define nucleic acid molecule
- describe isolation of nucleic acid molecule using standard molecular biology techniques
- introduce hybridization and cloning techniques
- describe amplification of nucleic acid using PCR
- introduce oligonucleotides corresponding to target nucleotide sequences
- describe complementary nucleic acid molecules
- introduce probes based on nucleotide sequence of target gene
- describe use of probes in diagnostic test kits
- introduce nucleic acid molecules with degeneracy of genetic code

### II. Isolated Proteins and Antibodies

- define isolated target proteins
- describe biologically active portions
- specify purification schemes
- outline recombinant DNA techniques
- define substantially free of cellular material
- define substantially free of chemical precursors
- describe biologically active portions
- specify percent identity of amino acid sequences
- outline algorithm for determining percent identity
- describe use of query sequence for database searches
- outline BLAST and Gapped BLAST programs
- define chimeric or fusion target proteins
- describe target polypeptide and non-target polypeptide
- outline fusion protein construction
- describe use of fusion proteins
- outline signal sequences for secretion and purification
- describe variants of target proteins as agonists or antagonists
- outline combinatorial libraries for variant identification
- describe use of isolated target proteins as immunogens

### III. Recombinant Expression Vectors and Host Cells

- define vector
- describe types of vectors
- explain autonomous replication
- explain integration into host genome
- describe expression vectors
- explain regulatory sequences
- describe operable linkage
- explain fusion expression vectors
- describe uses of fusion proteins
- describe E. coli expression vectors
- explain strategies for maximizing protein expression
- describe yeast expression vectors
- describe insect cell expression vectors
- describe mammalian expression vectors
- explain tissue-specific regulatory elements
- describe host cells

### IV. Pharmaceutical Compositions

- describe pharmaceutical compositions
- explain methods for preparing pharmaceutical compositions

### V. Drug Screening Assays

- describe drug screening assays
- explain sources of test compounds
- describe assay formats

### VI. Routes of Administration

- formulate pharmaceutical composition
- describe routes of administration
- list dosage forms for parenteral administration
- describe components of parenteral preparations
- outline methods for preparing sterile injectable solutions
- describe oral compositions and dosage forms
- list ingredients for oral compositions
- describe administration by inhalation
- describe transmucosal and transdermal administration
- describe controlled release formulations

### VI. Methods of Treatment

- describe prophylactic and therapeutic methods
- outline method of treating Alzheimer's Disease
- describe method of preventing cognitive impairments
- outline method of tailoring treatment based on pharmacogenomics
- describe method of preventing disease associated with target aberrancy
- outline agents that modulate target protein expression or activity
- describe method of modulating target protein expression or activity
- outline stimulatory and inhibitory agents
- describe method of treating AD or other cognitive impairments
- describe method of inhibiting AD or other cognitive impairments

### VII. Predictive Medicine

- relate to predictive medicine
- introduce diagnostic assays
- describe biological sample
- introduce antibody for detecting target protein
- define biological sample
- describe in vitro detection methods
- describe in vivo detection methods
- introduce control biological sample
- describe quantitative or qualitative assessment
- introduce traditional Northern blotting
- introduce RT-PCR
- introduce NASBA
- introduce Invader assay
- introduce hybridization-based assays
- describe nucleic acid hybridization
- introduce solid support-based assay formats
- describe oligonucleotide probe arrays
- introduce test probes
- introduce control probes
- describe normalization controls
- describe expression level controls
- describe mismatch controls
- compare expression profile to reference profile
- determine phenotype of sample

## EXAMPLES

### Example 1

- introduce experimental design
- describe animal subjects
- outline AAV vector preparation
- detail microinjection protocol
- describe qPCR analysis
- outline patch-clamp recording
- describe current-clamp intracellular recording
- detail Ca2+ imaging methods
- outline statistical analysis
- summarize results

### Example 2

- describe AAV-mediated overexpression of Fkbp1b
- summarize results of behavioral and electrophysiological tests

